relative dose intensity in older dlbcl patients
Published 4 years ago • 83 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
1:57
r-chop dose intensity and survival outcomes in dlbcl
-
2:05
alnuctamab: improved route of administration and optimized dose level & dosing schedule
-
0:45
difference between quality of life & patient-reported outcomes
-
3:04
applying molecular understanding of dlbcl to management strategies
-
6:12
coalition: glofitamab r-chop or glofitamab pola-r-chp in patients with high-risk dlbcl
-
10:07
understanding diffuse large b-cell lymphoma with bruce cheson, md, facp, faaas, fasco
-
1:03:49
2022 medical device product risk management (lincoln)
-
11:48
how to optimize the image quality of the veraview x800
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
2:06
effects of dose adjustment of first-line ibrutinib on real-world dosing patterns and outcomes in cll
-
2:20
the effect of ibrutinib dose-reduction on outcomes of patients with cll/sll: real-world evidence
-
2:22
the challenges with monitoring patients with lymphoma for cardiotoxicity
-
1:55
the real-world efficacy of brentuximab vedotin consolidation post-autosct in r/r hl
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
6:43
phase ii study of response-adapted ultra-low dose radiotherapy for b-cell lymphoma
-
3:24
15) uncertainty of measurement
-
2:41
an overview of the latest advances in hematology
-
1:53
clinical outcomes of btki ven treatment in cll/sll: double-exposed vs double-refractory patients
-
2:16
current and future treatment approaches for hr-mds
-
3:52
blood volume monitoring animation - crit-line® technology